A new study by WSU researchers suggests that a protein called CDK2 plays a critical role in heart damage caused by doxorubicin, a commonly used chemotherapy drug.
Identifying cancer and other health biomarkers in real-time is the aim of a software development project.
A promising but little-used type of cancer treatment has been markedly improved by introducing the use of tiny particles of gold and platinum.
By Eric Sorensen, WSU News
SPOKANE, Wash. – For the first time, WSU researchers have demonstrated a way to deliver a drug to a tumor by attaching it to a blood cell. The innovation could let doctors target tumors with anticancer drugs that might otherwise damage healthy tissues.
By Will Ferguson, College of Arts & Sciences
PULLMAN, Wash. – Technology being developed at Washington State University provides a non-invasive approach for diagnosing prostate cancer and tracking the disease’s progression.